91.15
price down icon1.32%   -1.22
 
loading

Guardant Health Inc Aktie (GH) Neueste Nachrichten

pulisher
Apr 01, 2026

Guardant Health Stock Rises on Japan Regulatory News for Daiichi Sankyo DrugNews and Statistics - IndexBox

Apr 01, 2026
pulisher
Apr 01, 2026

Director at Guardant Health (GH) acquires 155 shares via RSUs - Stock Titan

Apr 01, 2026
pulisher
Apr 01, 2026

Quarterly Recap: Can Guardant Health Inc maintain its current growth rate2026 Institutional Moves & Smart Allocation Stock Reports - baoquankhu1.vn

Apr 01, 2026
pulisher
Apr 01, 2026

Guardant Health (GH) Gains Momentum on Promising Outlook - GuruFocus

Apr 01, 2026
pulisher
Apr 01, 2026

Guardant Health gets oncology innovation accolade at Healthcare Asia Medtech Awards 2026 - Mugglehead Magazine

Apr 01, 2026
pulisher
Mar 31, 2026

Why Is Guardant Health (GH) Stock Soaring Today - Yahoo Finance

Mar 31, 2026
pulisher
Mar 31, 2026

Guardant Health (GH) partners with Manulife to launch Shield multi-cancer detection test in Asia - MSN

Mar 31, 2026
pulisher
Mar 31, 2026

Guardant Health (GH) and Verana Health Announces New Partnership - Insider Monkey

Mar 31, 2026
pulisher
Mar 31, 2026

INVESCO Small Cap Equity Fund's Guardant Health Inc(GH) Holding History - GuruFocus

Mar 31, 2026
pulisher
Mar 31, 2026

Guardant Health real-world data supports Japan approval of ENHERTU for HER2-positive tumors - MSN

Mar 31, 2026
pulisher
Mar 30, 2026

The Bull Case For Guardant Health (GH) Could Change Following Japan’s ENHERTU Approval Using Its AI Data - simplywall.st

Mar 30, 2026
pulisher
Mar 30, 2026

Guardant Health (GH) Supports Approval of Cancer Treatment in Ja - GuruFocus

Mar 30, 2026
pulisher
Mar 30, 2026

Guardant Health Inc (GH) Trading Down 3.96% on Mar 30 - GuruFocus

Mar 30, 2026
pulisher
Mar 30, 2026

Guardant Health's AI Data Supports ENHERTU Approval - National Today

Mar 30, 2026
pulisher
Mar 30, 2026

Guardant Health's Infinityai real-world evidence supports approval of Enhertu® for previously treated patients with HER2-positive metastatic solid tumors in Japan - MarketScreener

Mar 30, 2026
pulisher
Mar 30, 2026

Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan - Business Wire

Mar 30, 2026
pulisher
Mar 30, 2026

Liquid Biopsy Market Is Booming Rapidly with Strong Demand By 2033 | Guardant Health Inc., Foundation Medicine Inc. - openPR.com

Mar 30, 2026
pulisher
Mar 30, 2026

Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook - GlobeNewswire Inc.

Mar 30, 2026
pulisher
Mar 30, 2026

(GH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Mar 30, 2026
pulisher
Mar 29, 2026

5 High Growth Healthcare Stocks to Buy Now - Insider Monkey

Mar 29, 2026
pulisher
Mar 29, 2026

GH PE Ratio & Valuation, Is GH Overvalued - intellectia.ai

Mar 29, 2026
pulisher
Mar 29, 2026

Guardant Health to present new cancer research while stock trades lower amid strong sell signals - Traders Union

Mar 29, 2026
pulisher
Mar 29, 2026

Guardant Health Shares Fall as Market Reacts to Conflict, Policy Deadlines | 2026News and Statistics - IndexBox

Mar 29, 2026
pulisher
Mar 27, 2026

Why Guardant Health (GH) Stock Is Falling Today - Yahoo Finance

Mar 27, 2026
pulisher
Mar 27, 2026

Vanguard disaggregates holdings; reports 0% of Guardant Health (GH) - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

GH Stock Price, Quote & Chart | GUARDANT HEALTH INC (NASDAQ:GH) - ChartMill

Mar 27, 2026
pulisher
Mar 26, 2026

Guardant Health wins at Healthcare Asia Medtech Awards 2026 - healthcareasiamagazine.com

Mar 26, 2026
pulisher
Mar 26, 2026

Tempus AI Reinforces Market Position With Collaborations in 2026 - TradingView

Mar 26, 2026
pulisher
Mar 24, 2026

Guardant Health Ignites 5.6% Surge: A Volatile Breakout or a Trap for the Unwary? - Bitget

Mar 24, 2026
pulisher
Mar 24, 2026

Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data - Lelezard

Mar 24, 2026
pulisher
Mar 24, 2026

Verana and Guardant’s RWE Stack Aims to Solve Precision Oncology’s Data Challenges—Driving Growth Through Recurring Revenue and Broader Data Collections - Bitget

Mar 24, 2026
pulisher
Mar 23, 2026

Guardant Health Manulife Shield Partnership Highlights Asia Growth And Valuation Gap - Yahoo Finance

Mar 23, 2026
pulisher
Mar 23, 2026

Guardant Health (GH) director’s RSU vesting adds 264 common shares - Stock Titan

Mar 23, 2026
pulisher
Mar 23, 2026

How Guardant’s Shield Blood Test Rollout Through Quest Diagnostics (DGX) Has Changed Its Investment Story - Yahoo Finance

Mar 23, 2026
pulisher
Mar 21, 2026

GH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 21, 2026
pulisher
Mar 21, 2026

Multiple analysts lift Guardant Health, Inc. (GH) targets on screening and data growth - MSN

Mar 21, 2026
pulisher
Mar 21, 2026

Insiders Shake Up Guardant, Ovintiv, Redwire, Builders FirstSource, Permian - TipRanks

Mar 21, 2026
pulisher
Mar 20, 2026

Why Guardant Health’s (GH) 2026 screening story reinforced Piper Sandler’s bullish view - MSN

Mar 20, 2026
pulisher
Mar 20, 2026

Guardant Health (GH) Partners With Manulife to Launch Shield Multi-Cancer Detection Test in Asia - Insider Monkey

Mar 20, 2026
pulisher
Mar 20, 2026

Guardant Health to present 28 abstracts on multiomic cancer research at AACR26 - Traders Union

Mar 20, 2026
pulisher
Mar 20, 2026

Guardant Health, Inc. $GH Shares Sold by Polar Asset Management Partners Inc. - MarketBeat

Mar 20, 2026
pulisher
Mar 19, 2026

Insider Sell: Musa Tariq Sells Shares of Guardant Health Inc (GH) - GuruFocus

Mar 19, 2026
pulisher
Mar 19, 2026

Guardant Health (GH) director Tariq Musa sells $30,655 in stock By Investing.com - Investing.com Australia

Mar 19, 2026
pulisher
Mar 19, 2026

Insider Selling: Guardant Health (NASDAQ:GH) Director Sells 348 Shares of Stock - MarketBeat

Mar 19, 2026
pulisher
Mar 19, 2026

Guardant Health (GH) director Tariq Musa sells $30,655 in stock - Investing.com

Mar 19, 2026
pulisher
Mar 19, 2026

Guardant Health (NASDAQ: GH) director sells 348 company shares - Stock Titan

Mar 19, 2026
pulisher
Mar 19, 2026

3 Reasons to Steer Clear of GH and One Alternative Stock Worth Buying - Bitget

Mar 19, 2026
pulisher
Mar 19, 2026

Guardant Health Stock Analysis: Price Rise vs. Financial Risks | 2026News and Statistics - IndexBox

Mar 19, 2026
pulisher
Mar 19, 2026

3 Reasons to Avoid GH and 1 Stock to Buy Instead - Yahoo Finance

Mar 19, 2026
DGX DGX
$197.69
price up icon 0.87%
LH LH
$272.74
price up icon 2.22%
MTD MTD
$1,274.05
price up icon 1.02%
$203.21
price up icon 1.61%
IQV IQV
$172.40
price up icon 1.09%
WAT WAT
$299.89
price up icon 0.70%
Kapitalisierung:     |  Volumen (24h):